catechin has been researched along with Diabetes Mellitus, Type 2 in 88 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 14 (15.91) | 29.6817 |
2010's | 51 (57.95) | 24.3611 |
2020's | 23 (26.14) | 2.80 |
Authors | Studies |
---|---|
Chen, S; He, P; Li, B; Tu, Y; Wang, K; Wu, J; Zhao, H | 1 |
Chen, J; Jia, Q; Mehmood, S; Yang, R; Yang, X | 1 |
Ghosh, D; Jagdale, P; Kar, AK; Patnaik, S; Saji, J; Shraogi, N; Singh, A; Singh, D; Verma, R | 1 |
Jia, Q; Li, Y; Mehmood, S; Yang, R | 1 |
Chen, M; Chu, B; Lu, K; Ma, Y; Sun, H; Tao, Y; Zhang, Y | 1 |
Liang, S; Qin, M; Ren, X; Wang, Z; Zhang, M; Zhang, Y | 1 |
Asmara, AP; Prasansuklab, A; Tencomnao, T; Ung, AT | 1 |
Goto, C; Ito, A; Katashima, M; Kuriki, K; Matsui, Y; Takeshita, M | 1 |
James, A; Wang, K; Wang, Y | 1 |
Bao, J; Chen, F; Chen, J; Gan, W; Ren, K; Wang, M; Wang, T; Yu, P; Zhang, F; Zhang, Z | 1 |
Jin, L; Liang, G; Lv, Y; Wang, Y | 1 |
Lu, Y; Ren, Z; Yang, H; Yang, Z; Zhang, R | 1 |
Cremonini, E; Iglesias, DE; Kang, J; Lombardo, GE; Mostofinejad, Z; Oteiza, PI; Wang, Z; Zhu, W | 1 |
Huang, YW; Pang, QQ; Sheng, J; Wang, XJ; Yang, XY; Yu, CJ; Zhang, XJ; Zhu, QQ | 1 |
Li, S; Yang, L; Yi, J; Yin, L; Zhang, LM | 1 |
Hou, G; Liu, H; Liu, Q; Xi, X | 1 |
Diao, Y; Hu, X; Li, L; Li, X; Liu, H; Peng, J; Xu, Q; Yin, H; Yu, J; Zhang, C; Zhang, X; Zhang, Y | 1 |
Alejandra Castillo-Martinez, N; Alejandra Chavez-Santoscoy, R; Alejandra Ramírez-Rodríguez, A; Hidalgo-Ledesma, M; Leyva-Soto, A; Porras, O; Serrano-Medina, A | 1 |
Du, W; Huang, X; Wang, Y; Xu, J; Yin, G; Zheng, T | 1 |
Li, S; Li, X; Sui, Y; Sun, Z; Xie, B | 1 |
Fu, R; Li, B; Li, Z; Tan, H; Teng, W; Tian, J; Zhang, Y | 1 |
Wang, J; Wang, Z; Xin, C; Zhao, M | 1 |
Alipour, M; Allivand, M; Bazyar, H; Hosseini, SA; Labibzadeh, M; Mombaini, D; Saradar, S | 1 |
Chen, TY; Cooper, B; Ferruzzi, MG; Ho, L; Janle, EM; Pasinetti, GM; Simon, JE; Talcott, ST; Todd, G; Wang, J; Wu, QL | 1 |
Inagaki, Y; Kato, E; Kawabata, J; Kurokawa, M; Kushibiki, N | 1 |
Bhakta, HK; Choi, JS; Fujii, H; Jung, HA; Park, CH; Paudel, P; Sato, A; Yokozawa, T | 1 |
Adelsbach, M; Berk, L; Ellinger, S; Helfrich, HP; Kirch, N; Liegl, Y; Ludwig, N; Schieber, A; Stehle, P; Stoffel-Wagner, B; Zimmermann, BF | 1 |
Guan, Y; Li, Y; Ling, F; Niu, Y; Wu, Y; Yuan, H; Zhang, C; Zhang, Q | 1 |
Chen, M; Li, S; Li, X; Sun, Z; Wang, J; Xie, B | 1 |
Cao, L; Cui, C; Ho, CT; Li, D; Long, P; Meng, Q; Wan, X; Wang, Y; Zhang, L; Zhou, J | 1 |
Cremonini, E; Fraga, CG; Oteiza, PI | 1 |
Casanova, E; Crescenti, A; Gibert-Ramos, A; Salvadó, J | 1 |
Rimbach, G; Schrader, E; Wein, S; Wolffram, S | 1 |
Ahn, S; Bae, JH; Bae, KC; Cho, HC; Choi, YJ; Im, SS; Kim, SP; Kim, YW; Park, JH; Song, DK | 1 |
Ceballos, G; Ciaraldi, TP; Coral-Vazquez, R; Gonzalez-Basurto, S; Henry, RR; Hogan, M; Maisel, AS; Perkins, G; Ramirez-Sanchez, I; Taub, PR; Villarreal, F | 1 |
Baba, M; Ishii, K; Muroi, K; Osada, K; Uematsu, H; Yui, K | 1 |
Ceballos, G; Ciaraldi, TP; Coe, T; Henry, RR; Hogan, M; Maisel, AS; Nogueira, L; Perkins, G; Ramirez-Sanchez, I; Taub, PR; Villarreal, F | 1 |
Chan, KC; Chang, YH; Chao, YC; Huang, SM; Lai, CY; Lin, JA; Tseng, ST; Wu, CH; Yen, GC | 1 |
Matsui, T; Miyata, Y; Nagata, Y; Tamaru, S; Tamaya, K; Tanaka, K; Tanaka, T | 1 |
Kim, JJ; Qu, X; Sun, YL; Tan, Y; Xiao, L | 1 |
Goda, T; Mochizuki, K; Suzuki, T; Uchiyama, Y | 2 |
Liu, CX; Min, LQ; Song, CG; Yang, X; Zhao, CS | 1 |
Noh, JS; Park, CH; Yokozawa, T | 1 |
Gu, D; Hu, G; Jiao, H; Ni, X | 1 |
Ardevol, A; Arola, L; Blay, M; Casanova-Marti, A; Gonzalez-Abuin, N; Pinent, M | 1 |
Keske, MA; Kim, JA; Munir, K; Ng, HL; Premilovac, D; Quon, MJ; Rattigan, S; Yang, P | 1 |
Cordero-Herrera, I; Goya, L; Martín, MA; Ramos, S | 1 |
Choi, JS; Chung, HY; Fujii, H; Noh, JS; Park, CH; Roh, SS; Song, YO; Yokozawa, T | 1 |
Cassidy, A; Franke, AA; Hu, FB; Pan, A; Rimm, EB; Sun, Q; Townsend, MK; Tworoger, SS; van Dam, RM; Wedick, NM | 1 |
Cai, Q; Cheng, M; Gao, H; Li, B; Li, X; Yin, W; Yu, F; Zhang, Z | 1 |
Huang, J; Wang, Y; Yang, CS; Zhang, J; Zhang, L | 1 |
Brender, JR; Fierke, CA; Pithadia, A; Ramamoorthy, A | 1 |
Chang, SJ; Liu, HW; Wei, CC | 1 |
Ceballos, G; Moreno-Ulloa, A; Ramírez-Sánchez, I; Rodríguez, A; Villarreal, F | 1 |
Moreno-Ulloa, A; Moreno-Ulloa, J | 1 |
Afshari, G; Ahangarpour, A; Hashemitabar, M; Khodadadi, A; Mard, SA | 1 |
Ishizaki, Y; Kikuzaki, H; Kobayashi, K; Kojo, S | 1 |
Botelho, PB; de Morais, AC; Ferreira, MA; Mota, JF; Silva, DM | 1 |
Fujimoto, S; Fujita, N; Inagaki, N; Mukai, E; Nagashima, K; Ogura, K; Ogura, M; Sato, H; Sato, Y; Shoji, T; Sugizaki, K; Tahara, Y; Tatsuoka, H; Usui, R; Yamano, G | 1 |
Chen, CH; He, YM; Li, ZH; Ma, GL; Xu, LH; Xu, ZX; Yang, HJ; Zhang, Q; Zhang, Y; Zhou, GR; Zhou, P | 1 |
Hase, T; Komikado, M; Meguro, S; Nagao, T; Otsuka, K; Tokimitsu, I; Yamamoto, K; Yamamoto, T | 1 |
Arnason, JT; Beaulieu, LP; Haddad, PS; Harris, CS; McIntyre, KL; Saleem, A; Ta, CA | 1 |
Chang, K; Ihm, SH; Kim, SJ; Lee, JO; Oak, MH; Schini-Kerth, VB; Seung, KB | 1 |
Chaiyasut, C; Jaikang, C; Kusirisin, W; Lailerd, N; Lerttrakarnnon, P; Srichairatanakool, S; Suttajit, M | 1 |
Matalka, KZ; Nahrstedt, A; Petereit, F; Qa'dan, F; Verspohl, EJ | 1 |
Cai, EP; Lin, JK | 1 |
Fujii, H; Kim, HY; Noh, JS; Park, CH; Yokozawa, T | 1 |
Abedini, A; Meng, F; Plesner, A; Raleigh, DP; Verchere, CB | 1 |
Huang, C; Jia, Q; Li, Y; Lu, Z; Wang, R; Wu, X; Wu, Y | 1 |
Baer, DJ; Clevidence, B; Harris, GK; Novotny, JA; Rumpler, WV; Stote, K | 1 |
Fukutomi, R; Imai, S; Isemura, M; Ishigami, Y; Miyoshi, N; Tanabe, H; Yasui, K | 1 |
Chou, P; Hsu, CH; Huang, CJ; Liao, YL; Lin, SC; Tsai, TH | 1 |
Jungbauer, A; Liebner, F; Zoechling, A | 1 |
Feng, Z; Liu, J; Long, J; Shen, W; Wang, Y; Weber, P; Wertz, K; Yan, J | 1 |
Kai, G; Wang, H; Xiao, J; Yang, F; Yuan, Y; Zhang, C; Zhao, Y | 1 |
Ceballos, G; Ciaraldi, TP; Henry, RR; Hogan, M; Maisel, AS; Murphy, AN; Naviaux, R; Perkins, G; Ramirez-Sanchez, I; Taub, PR; Villarreal, F | 1 |
Gradinaru, D; Ilie, M; Margina, D | 1 |
Chen, K; Chen, L; Jia, Q; Li, Y; Sun, P; Wang, H; Wang, T | 1 |
Du, WH; Liu, ZH; Peng, SM; Shi, L; Tan, LF; Zou, XQ | 1 |
Rizvi, SI; Zaid, MA | 3 |
Zaveri, NT | 1 |
Ardévol, A; Arola, L; Bladé, C; Blay, M; Fernández-Larrea, J; Pinent, M; Pujadas, G; Salvadó, MJ | 1 |
Preller, M; Raederstorff, D; Riegger, C; Teixeira, SR; Wang, Y; Weber, P; Wolfram, S | 1 |
Goda, T; Mochizuki, K; Sakurai, N; Shimada, M | 1 |
Giampietro, O; Matteucci, E; Rizvi, SI | 1 |
13 review(s) available for catechin and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Therapeutic Activity of Green Tea Epigallocatechin-3-Gallate on Metabolic Diseases and Non-Alcoholic Fatty Liver Diseases: The Current Updates.
Topics: Antioxidants; Catechin; Diabetes Mellitus, Type 2; Humans; Metabolic Diseases; Non-alcoholic Fatty Liver Disease; Obesity; Polyphenols; Tea | 2023 |
(-)-Epicatechin and the comorbidities of obesity.
Topics: Animals; Blood Glucose; Cardiovascular Diseases; Catechin; Comorbidity; Diabetes Mellitus, Type 2; Dysbiosis; Dyslipidemias; Endoplasmic Reticulum; Endotoxins; Flavonoids; Humans; Inflammation; Insulin Resistance; Lipid Metabolism; Mental Disorders; Mitochondria; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress | 2020 |
(-)-Epicatechin in the control of glucose homeostasis: Involvement of redox-regulated mechanisms.
Topics: Animals; Catechin; Diabetes Mellitus, Type 2; Diet, High-Fat; Glucose; Homeostasis; Humans; Insulin Resistance; Obesity; Oxidation-Reduction | 2019 |
Epigallocatechin Gallate Modulates Muscle Homeostasis in Type 2 Diabetes and Obesity by Targeting Energetic and Redox Pathways: A Narrative Review.
Topics: Animals; Catechin; Diabetes Mellitus, Type 2; Disease Models, Animal; Energy Metabolism; Epigenesis, Genetic; Glucose; Homeostasis; Humans; Lipid Metabolism; Muscle, Skeletal; NF-kappa B; Obesity; Oxidative Stress; Signal Transduction | 2019 |
Having a promising efficacy on type II diabetes, it's definitely a green tea time.
Topics: Animals; Antioxidants; Catechin; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Insulin; Polyphenols; Polysaccharides; Signal Transduction; Tea | 2015 |
Procyanidins and their healthy protective effects against type 2 diabetes.
Topics: Animals; Biflavonoids; Catechin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin-Secreting Cells; Proanthocyanidins | 2015 |
Vascular and metabolic actions of the green tea polyphenol epigallocatechin gallate.
Topics: Adipose Tissue; Animals; Cardiovascular Diseases; Catechin; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Liver; Muscle, Skeletal; Nitric Oxide; Tea | 2015 |
Oligonol, a low-molecular-weight polyphenol derived from lychee fruit, attenuates gluco-lipotoxicity-mediated renal disorder in type 2 diabetic db/db mice.
Topics: Animals; Apoptosis; Catechin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glycation End Products, Advanced; Kidney; Lipid Metabolism; Litchi; Mice; Phenols; Reactive Oxygen Species | 2015 |
Mechanisms of body weight reduction and metabolic syndrome alleviation by tea.
Topics: Adipose Tissue; AMP-Activated Protein Kinases; Animals; Camellia sinensis; Cardiovascular Diseases; Catechin; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Liver; Meta-Analysis as Topic; Metabolic Syndrome; Muscle, Skeletal; Plant Leaves; Polyphenols; Randomized Controlled Trials as Topic; Risk Factors; Tea; Weight Loss | 2016 |
Inhibition of IAPP Aggregation and Toxicity by Natural Products and Derivatives.
Topics: Catechin; Curcumin; Diabetes Mellitus, Type 2; Humans; Insulin-Secreting Cells; Islet Amyloid Polypeptide; Resveratrol; Stilbenes | 2016 |
Therapeutic potential of green tea on risk factors for type 2 diabetes in obese adults - a review.
Topics: Animals; Antioxidants; Body Composition; Catechin; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Inflammation; Insulin Resistance; Meta-Analysis as Topic; Obesity; Oxidative Stress; Phytotherapy; Randomized Controlled Trials as Topic; Risk Factors; Tea | 2016 |
Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications.
Topics: Aging; Animals; Anticarcinogenic Agents; Bacterial Infections; Cardiovascular Diseases; Catechin; Diabetes Mellitus, Type 2; Flavonoids; Humans; Neurodegenerative Diseases; Obesity; Phenols; Polyphenols; Tea | 2006 |
Procyanidin effects on adipocyte-related pathologies.
Topics: Adipocytes; Biflavonoids; Catechin; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Obesity; Proanthocyanidins | 2006 |
9 trial(s) available for catechin and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Epicatechin and quercetin exhibit in vitro antioxidant effect, improve biochemical parameters related to metabolic syndrome, and decrease cellular genotoxicity in humans.
Topics: Antioxidants; Caco-2 Cells; Catechin; Diabetes Mellitus, Type 2; Humans; Metabolic Syndrome; Quercetin | 2021 |
Effects of epigallocatechin-3-gallate of
Topics: Antioxidants; Biomarkers; Blood Pressure; Camellia sinensis; Catechin; Diabetes Mellitus, Type 2; Flour; Humans; Lipids; Plant Leaves; Triticum | 2020 |
A nutritive dose of pure (-)-epicatechin does not beneficially affect increased cardiometabolic risk factors in overweight-to-obese adults-a randomized, placebo-controlled, double-blind crossover study.
Topics: Adult; Aged; Cardiovascular Diseases; Catechin; Cross-Over Studies; Diabetes Mellitus, Type 2; Dietary Supplements; Double-Blind Method; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Overweight; Risk Factors; Young Adult | 2018 |
(-)-Epicatechin rich cocoa mediated modulation of oxidative stress regulators in skeletal muscle of heart failure and type 2 diabetes patients.
Topics: Aged; Animals; Beverages; Cacao; Catechin; Diabetes Mellitus, Type 2; Female; Heart Failure; Humans; Male; Mice; Mice, Inbred C57BL; Middle Aged; Muscle, Skeletal; Oxidative Stress; Pilot Projects | 2013 |
EGCG-rich green tea extract stimulates sRAGE secretion to inhibit S100A12-RAGE axis through ADAM10-mediated ectodomain shedding of extracellular RAGE in type 2 diabetes.
Topics: ADAM Proteins; ADAM10 Protein; Amyloid Precursor Protein Secretases; Camellia sinensis; Catechin; Diabetes Mellitus, Type 2; Female; Humans; Male; Membrane Proteins; Middle Aged; Monocytes; Plant Extracts; Protein Structure, Tertiary; Receptor for Advanced Glycation End Products; Receptors, Immunologic; S100 Proteins; S100A12 Protein | 2013 |
The effect of procyanidin on expression of STAT1 in type 2 diabetes mellitus SD rats with focal cerebral ischemia.
Topics: Animals; Apoptosis; Biflavonoids; Brain Ischemia; Catechin; Diabetes Mellitus, Type 2; Disease Models, Animal; Gene Expression Regulation; Janus Kinases; Male; Neuroprotective Agents; Proanthocyanidins; Rats; Rats, Sprague-Dawley; Signal Transduction; STAT1 Transcription Factor | 2014 |
A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes.
Topics: Adiponectin; Adipose Tissue; Aged; Beverages; Blood Glucose; Blood Pressure; Catechin; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipid Metabolism; Male; Middle Aged; Obesity | 2009 |
Oolong tea does not improve glucose metabolism in non-diabetic adults.
Topics: Adult; Beverages; Blood Glucose; Catechin; Cross-Over Studies; Diabetes Mellitus, Type 2; Diet; Dietary Supplements; Double-Blind Method; Fasting; Flavonoids; Glucose Tolerance Test; Humans; Insulin; Male; Middle Aged; Phenols; Polyphenols; Self Report; Tea | 2011 |
Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial.
Topics: Adult; Antioxidants; Body Mass Index; Catechin; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Insulin Resistance; Lipid Metabolism; Male; Middle Aged; Obesity; Prospective Studies; Tea; Treatment Outcome; Waist-Hip Ratio; Weight Loss; Young Adult | 2011 |
66 other study(ies) available for catechin and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Transcriptome analysis provides insight into the anti-diabetic mechanism of theaflavins in high-fat diet and streptozotocin-induced mice.
Topics: Animals; Antioxidants; Biflavonoids; Blood Glucose; Catechin; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Gene Expression Profiling; Insulin Resistance; Liver; Male; Mice; Mice, Inbred C57BL; Streptozocin; Tea | 2022 |
Epigallocatechin-3-gallate ameliorates renal endoplasmic reticulum stress-mediated inflammation in type 2 diabetic rats.
Topics: Animals; Catechin; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Endoplasmic Reticulum Stress; Hyperglycemia; Inflammasomes; Inflammation; Male; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Tea | 2022 |
Biopolymeric composite hydrogel loaded with silver NPs and epigallocatechin gallate (EGCG) effectively manages ROS for rapid wound healing in type II diabetic wounds.
Topics: Animals; Catechin; Diabetes Mellitus, Type 2; Hydrogels; Mice; Mice, Inbred C57BL; Reactive Oxygen Species; Silver; Wound Healing | 2022 |
Epigallocatechin-3-gallate attenuates myocardial fibrosis in diabetic rats by activating autophagy.
Topics: Adenosine; AMP-Activated Protein Kinases; Animals; Autophagy; Beclin-1; Blood Glucose; Catechin; Collagen; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Fibrosis; Hydroxyproline; Hypertrophy; Mammals; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Microtubule-Associated Proteins; Rats; TOR Serine-Threonine Kinases; Transforming Growth Factor beta1 | 2022 |
Natural 8-C-ascorbyl-(-)-epigallocatechin as antidiabetic agent: α-glucosidase and PTP-1B signaling pathway dual regulators.
Topics: Acarbose; alpha-Glucosidases; Antioxidants; Ascorbic Acid; Blood Glucose; Catechin; Diabetes Mellitus, Type 2; Food Ingredients; Glucose; Glycogen Synthase Kinase 3 beta; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulins; Molecular Docking Simulation; Molecular Structure; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Proto-Oncogene Proteins c-akt; Signal Transduction; Tea | 2022 |
Highland Barley Polyphenol Delayed the In Vitro Digestibility of Starch and Amylose by Modifying Their Structural Properties.
Topics: Acetone; Amylose; Catechin; Coumaric Acids; Diabetes Mellitus, Type 2; Digestion; Hordeum; Hypoglycemic Agents; Methanol; Phenols; Polyphenols; Resistant Starch; Starch | 2022 |
Identification of Phytochemicals in Bioactive Extracts of
Topics: Acacia; alpha-Glucosidases; Antioxidants; Australia; Catechin; Diabetes Mellitus, Type 2; Humans; Phytochemicals; Plant Extracts | 2023 |
Gut microbiota-mediated associations of green tea and catechin intakes with glucose metabolism in individuals without type 2 diabetes mellitus: a four-season observational study with mediation analysis.
Topics: Adult; Blood Glucose; Catechin; Diabetes Mellitus, Type 2; Gastrointestinal Microbiome; Humans; Male; Mediation Analysis; Seasons; Tea | 2023 |
Beneficial effects of green tea on age related diseases.
Topics: Aging; Camellia sinensis; Catechin; Diabetes Mellitus, Type 2; Functional Food; Humans; Metabolic Syndrome; Obesity; Plant Extracts; Tea | 2020 |
Revealing the Mechanism of EGCG, Genistein, Rutin, Quercetin, and Silibinin Against hIAPP Aggregation via Computational Simulations.
Topics: Catechin; Diabetes Mellitus, Type 2; Genistein; Humans; Islet Amyloid Polypeptide; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Quercetin; Rutin; Silybin | 2020 |
Anti‑glycolipid disorder effect of epigallocatechin‑3‑gallate on high‑fat diet and STZ‑induced T2DM in mice.
Topics: Animals; Blood Glucose; Catechin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Endothelial Cells; Glycolipids; Hypercholesterolemia; Hyperlipidemias; Insulin Resistance; Lipids; Lipoproteins, LDL; Male; Mice; Mice, Inbred C57BL; Sterol Regulatory Element Binding Protein 2; Streptozocin | 2020 |
EGCG targeting Notch to attenuate renal fibrosis
Topics: Animals; Antioxidants; Catechin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Female; Injections, Intraperitoneal; Mice; Mice, Inbred ICR; Random Allocation; Renal Insufficiency, Chronic; Signal Transduction; Smad3 Protein; Streptozocin; Transforming Growth Factor beta | 2020 |
Insight into interaction mechanism between theaflavin-3-gallate and α-glucosidase using spectroscopy and molecular docking analysis.
Topics: alpha-Glucosidases; Biflavonoids; Catechin; Diabetes Mellitus, Type 2; Glycoside Hydrolase Inhibitors; Humans; Molecular Docking Simulation; Spectrum Analysis | 2021 |
[Effects of swimming and epigallocatechin gallate on interstitial proteins expression of myocardium from type 2 diabetic rats].
Topics: Animals; Catechin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Male; Myocardium; Rats; Rats, Sprague-Dawley; Swimming; Transforming Growth Factor beta1 | 2021 |
Epigallocatechin-3-gallate prevents inflammation and diabetes -Induced glucose tolerance through inhibition of NLRP3 inflammasome activation.
Topics: Animals; Anti-Inflammatory Agents; Bone Marrow; Catechin; Cells, Cultured; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Glucose Tolerance Test; Humans; Inflammasomes; Inflammation; Macrophages; Mice; Mice, Inbred C57BL; NLR Family, Pyrin Domain-Containing 3 Protein; Pyroptosis | 2021 |
Procyanidine resists the fibril formation of human islet amyloid polypeptide.
Topics: Alzheimer Disease; Amyloid; Biflavonoids; Catechin; Diabetes Mellitus, Type 2; Humans; Islet Amyloid Polypeptide; Proanthocyanidins | 2021 |
Diabetes diminishes a typical metabolite of litchi pericarp oligomeric procyanidins (LPOPC) in urine mediated by imbalanced gut microbiota.
Topics: Animals; Antioxidants; Biflavonoids; Catechin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fasting; Fruit; Gastrointestinal Microbiome; Litchi; Male; Plant Extracts; Proanthocyanidins; Rats; Rats, Sprague-Dawley; RNA, Ribosomal, 16S | 2021 |
Characteristics of the interaction mechanisms of procyanidin B1 and procyanidin B2 with protein tyrosine phosphatase-1B: Analysis by kinetics, spectroscopy methods and molecular docking.
Topics: Biflavonoids; Catechin; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Humans; Kinetics; Molecular Docking Simulation; Proanthocyanidins; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Spectrum Analysis | 2021 |
Hawthorn polyphenols, D-chiro-inositol, and epigallocatechin gallate exert a synergistic hypoglycemic effect.
Topics: Animals; Catechin; Crataegus; Diabetes Mellitus, Type 2; Glycogen Synthase Kinase 3; Hypoglycemic Agents; Inositol; Mice; Phosphatidylinositol 3-Kinases; Polyphenols | 2021 |
Influence of diabetes on plasma pharmacokinetics and brain bioavailability of grape polyphenols and their phase II metabolites in the Zucker diabetic fatty rat.
Topics: Animals; Anthocyanins; Biological Availability; Blood Glucose; Brain; Catechin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Flavonoids; Grape Seed Extract; Male; Polyphenols; Quercetin; Rats; Rats, Zucker; Resveratrol; Stilbenes; Tandem Mass Spectrometry; Vitis | 2017 |
Astilbe thunbergii reduces postprandial hyperglycemia in a type 2 diabetes rat model via pancreatic alpha-amylase inhibition by highly condensed procyanidins.
Topics: Animals; Biflavonoids; Catechin; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucagon-Like Peptide-1 Receptor; Glycoside Hydrolase Inhibitors; Hyperglycemia; Male; Proanthocyanidins; Rats; Saxifragaceae | 2017 |
Oligonol promotes glucose uptake by modulating the insulin signaling pathway in insulin-resistant HepG2 cells via inhibiting protein tyrosine phosphatase 1B.
Topics: Catechin; Diabetes Mellitus, Type 2; Gluconeogenesis; Glucose; Hep G2 Cells; Humans; Hypoglycemic Agents; Inflammation; Insulin; Insulin Resistance; NF-kappa B; Oxidative Stress; Phenols; Phosphatidylinositol 3-Kinase; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Signal Transduction | 2017 |
Epigallocatechin gallate improves insulin resistance in HepG2 cells through alleviating inflammation and lipotoxicity.
Topics: Animals; Catechin; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Hep G2 Cells; Humans; Inflammation; Insulin Resistance; Oxidative Stress; Rats; Transfection | 2018 |
(-)-Epigallocatechin-3-gallate (EGCG) inhibits starch digestion and improves glucose homeostasis through direct or indirect activation of PXR/CAR-mediated phase II metabolism in diabetic mice.
Topics: alpha-Amylases; alpha-Glucosidases; Animals; Camellia sinensis; Catechin; Constitutive Androstane Receptor; Diabetes Mellitus, Type 2; Gluconeogenesis; Glucose; Homeostasis; Humans; Intestine, Small; Lipogenesis; Liver; Male; Mice; Mice, Inbred ICR; Plant Extracts; Pregnane X Receptor; Receptors, Cytoplasmic and Nuclear; Starch; Sterol Regulatory Element Binding Protein 1 | 2018 |
Roasting improves the hypoglycemic effects of a large-leaf yellow tea infusion by enhancing the levels of epimerized catechins that inhibit α-glucosidase.
Topics: alpha-Glucosidases; Animals; Blood Glucose; Camellia sinensis; Catechin; Cooking; Diabetes Mellitus, Type 2; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Plant Extracts; Plant Leaves; Starch; Tea | 2018 |
Oral green tea catechins transiently lower plasma glucose concentrations in female db/db mice.
Topics: Adiponectin; Adipose Tissue; Animals; Anti-Inflammatory Agents; Blood Glucose; Camellia sinensis; Catechin; Diabetes Mellitus, Type 2; Dietary Supplements; Female; Flavonoids; Hyperglycemia; Hypoglycemic Agents; Inflammation; Intercellular Adhesion Molecule-1; Mice; Mice, Knockout; Mice, Obese; Obesity; Phytotherapy; Plant Extracts; Rosiglitazone; Thiazolidinediones; Tumor Necrosis Factor-alpha; Weight Gain | 2013 |
Green tea extract with polyethylene glycol-3350 reduces body weight and improves glucose tolerance in db/db and high-fat diet mice.
Topics: Adiponectin; Adipose Tissue; Animals; Anti-Obesity Agents; Caco-2 Cells; Camellia sinensis; Catechin; Diabetes Mellitus, Type 2; Diet, High-Fat; Glucose; Glucose Intolerance; Humans; Insulin Resistance; Male; Mice; Mice, Inbred C57BL; Obesity; Organ Size; Plant Extracts; Polyethylene Glycols; Retinol-Binding Proteins, Plasma | 2013 |
Perturbations in skeletal muscle sarcomere structure in patients with heart failure and type 2 diabetes: restorative effects of (-)-epicatechin-rich cocoa.
Topics: Aged; Blotting, Western; Cacao; Catechin; Diabetes Mellitus, Type 2; Dysferlin; Dystrophin; Dystrophin-Associated Protein Complex; Exercise Test; Heart Failure; Humans; Immunohistochemistry; Male; Membrane Proteins; Microscopy, Electron, Transmission; Middle Aged; Muscle Proteins; Muscle, Skeletal; Pilot Projects; Sarcoglycans; Sarcomeres; Treatment Outcome; Utrophin | 2013 |
Effect of dietary polyphenols from hop (Humulus lupulus L.) pomace on adipose tissue mass, fasting blood glucose, hemoglobin A1c, and plasma monocyte chemotactic protein-1 levels in OLETF rats.
Topics: Adipose Tissue; Animals; Blood Glucose; Catechin; Diabetes Mellitus, Type 2; Dietary Supplements; Disease Models, Animal; Fasting; Glucosephosphate Dehydrogenase; Humulus; Malate Dehydrogenase; Male; Rats; Sterol Regulatory Element Binding Protein 1; Triglycerides | 2013 |
Theflavins and theasinensin A derived from fermented tea have antihyperglycemic and hypotriacylglycerolemic effects in KK-A(y) mice and Sprague-Dawley rats.
Topics: Animals; Benzopyrans; Biflavonoids; Camellia sinensis; Catechin; Diabetes Mellitus, Type 2; Dietary Supplements; Eriobotrya; Fermentation; Gallic Acid; Hypertriglyceridemia; Hypoglycemic Agents; Hypolipidemic Agents; Japan; Male; Mice; Mice, Inbred Strains; Phenols; Plant Leaves; Rats; Rats, Sprague-Dawley; Tea; Triglycerides | 2013 |
Green tea polyphenol epigallocatechin-3-gallate enhance glycogen synthesis and inhibit lipogenesis in hepatocytes.
Topics: Antioxidants; Catechin; Diabetes Mellitus, Type 2; Glycogen; Hep G2 Cells; Hepatocytes; Humans; Lipid Metabolism; Lipogenesis; Metabolic Syndrome; Phosphorylation; Proto-Oncogene Proteins c-akt; Tea | 2013 |
Dietary supplementation with (-)-epigallocatechin-3-gallate reduces inflammatory response in adipose tissue of non-obese type 2 diabetic Goto-Kakizaki (GK) rats.
Topics: Adipose Tissue; Animals; Blood Glucose; Body Weight; Catechin; Diabetes Mellitus, Type 2; Dietary Supplements; Gene Expression Regulation; Inflammation; Male; Obesity; Oxidative Stress; Rats; Rats, Wistar | 2013 |
Dietary supplementation with a low dose of (-)-epigallocatechin-3-gallate reduces pro-inflammatory responses in peripheral leukocytes of non-obese type 2 diabetic GK rats.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Analysis of Variance; Animals; Catechin; Chemokines; Corn Oil; Cytokines; Deoxyguanosine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet; Diet, High-Fat; Dietary Fats; Dietary Supplements; Disease Models, Animal; Inflammation; Leukocytes; Male; Malondialdehyde; Oxidative Stress; Polymerase Chain Reaction; Rats; Rats, Wistar | 2013 |
Oligonol, a low-molecular-weight polyphenol derived from lychee fruit, attenuates diabetes-induced renal damage through the advanced glycation end product-related pathway in db/db mice.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Blood Urea Nitrogen; Caspase 3; Catechin; Creatinine; Diabetes Mellitus, Type 2; Fruit; Glycation End Products, Advanced; Inhibitor of Apoptosis Proteins; JNK Mitogen-Activated Protein Kinases; Kidney; Litchi; Male; Mice; Mice, Inbred C57BL; NADPH Oxidase 4; NADPH Oxidases; Organ Size; Oxidative Stress; Phenols; Plant Extracts; Polyphenols; Reactive Oxygen Species; Repressor Proteins; Survivin; Tumor Necrosis Factor-alpha | 2014 |
Cocoa flavonoids protect hepatic cells against high-glucose-induced oxidative stress: relevance of MAPKs.
Topics: Antioxidants; Cacao; Catechin; Diabetes Mellitus, Type 2; Flavonoids; Glucose; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Hep G2 Cells; Hepatocytes; Humans; Hypoglycemic Agents; Insulin Receptor Substrate Proteins; Insulin Resistance; Mitogen-Activated Protein Kinases; NF-E2-Related Factor 2; Oxidative Stress; Phenols; Phosphorylation; Plant Extracts; Reactive Oxygen Species; Up-Regulation | 2015 |
Urinary Excretion of Select Dietary Polyphenol Metabolites Is Associated with a Lower Risk of Type 2 Diabetes in Proximate but Not Remote Follow-Up in a Prospective Investigation in 2 Cohorts of US Women.
Topics: Adult; Aged; Aged, 80 and over; Caffeic Acids; Case-Control Studies; Catechin; Coumaric Acids; Diabetes Mellitus, Type 2; Female; Flavanones; Follow-Up Studies; Hesperidin; Humans; Hydroxybenzoates; Middle Aged; Nutrition Assessment; Polyphenols; Prospective Studies; Quercetin; Risk Factors; Surveys and Questionnaires | 2015 |
Anti-inflammatory effects of grape seed procyanidin B2 on a diabetic pancreas.
Topics: Animals; Anti-Inflammatory Agents; Antigens, Surface; Biflavonoids; Carrier Proteins; Catechin; Diabetes Mellitus, Type 2; Humans; Interleukin-1beta; Male; Mice; Mice, Inbred C57BL; Milk Proteins; NLR Family, Pyrin Domain-Containing 3 Protein; Pancreas; Plant Extracts; Proanthocyanidins; Seeds; Vitis | 2015 |
Low-molecular-weight polyphenols protect kidney damage through suppressing NF-κB and modulating mitochondrial biogenesis in diabetic db/db mice.
Topics: Animals; Camellia sinensis; Catechin; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Fruit; Humans; Interleukin-6; Litchi; Male; Mice; Mice, Inbred C57BL; Mitochondria; Molecular Weight; NF-kappa B; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phenols; Plant Extracts; Polyphenols; Protective Agents | 2016 |
(-)-Epicatechin-induced recovery of mitochondria from simulated diabetes: Potential role of endothelial nitric oxide synthase.
Topics: Animals; Catechin; Cells, Cultured; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Endothelial Cells; Enzyme Inhibitors; Humans; Mice, Inbred C57BL; Mitochondria, Heart; Myocardium; Nitric Oxide; Nitric Oxide Synthase Type III; Organelle Biogenesis; Phosphorylation; RNA Interference; Signal Transduction; Transfection | 2016 |
Mortality reduction among persons with type 2 diabetes: (-)-Epicatechin as add-on therapy to metformin?
Topics: Animals; Cardiovascular Diseases; Catechin; Chocolate; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Metformin; Myocardial Infarction; Rats; Reperfusion Injury | 2016 |
Preventive effects of procyanidin A2 on glucose homeostasis, pancreatic and duodenal homebox 1, and glucose transporter 2 gene expression disturbance induced by bisphenol A in male mice.
Topics: Animals; Apoptosis; Benzhydryl Compounds; Blood Glucose; Catechin; Cells, Cultured; Diabetes Mellitus, Type 2; Gene Expression; Glucose Transporter Type 2; Homeodomain Proteins; Homeostasis; Hyperglycemia; Insulin; Islets of Langerhans; Male; Malondialdehyde; Mice; Phenols; Proanthocyanidins; RNA, Messenger; Trans-Activators | 2016 |
Strong Inhibition of Secretory Sphingomyelinase by Catechins, Particularly by (-)-Epicatechin 3-O-Gallate and (-)-3'-O-Methylepigallocatechin 3-O-Gallate.
Topics: Animals; Atherosclerosis; Catechin; Diabetes Mellitus, Type 2; Disease Models, Animal; Hydrogen-Ion Concentration; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Sphingomyelin Phosphodiesterase | 2016 |
Oral Administration of Apple Procyanidins Ameliorates Insulin Resistance via Suppression of Pro-Inflammatory Cytokine Expression in Liver of Diabetic ob/ob Mice.
Topics: Animals; Biflavonoids; Catechin; Cytokines; Diabetes Mellitus, Type 2; Humans; Insulin; Insulin Resistance; Liver; Male; Malus; Mice; Mice, Inbred C57BL; Plant Extracts; Proanthocyanidins | 2016 |
Influence of Aluminium and EGCG on Fibrillation and Aggregation of Human Islet Amyloid Polypeptide.
Topics: Aluminum; Amyloid; Catechin; Chelating Agents; Diabetes Mellitus, Type 2; Humans; Islet Amyloid Polypeptide; Kinetics; Light; Magnetic Resonance Spectroscopy; Microscopy, Electron, Transmission; Scattering, Radiation; Spectrometry, Fluorescence; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet | 2016 |
Seasonal phytochemical variation of anti-glycation principles in lowbush blueberry (Vaccinium angustifolium).
Topics: Animals; Antioxidants; Blueberry Plants; Catechin; Cattle; Chlorogenic Acid; Diabetes Mellitus, Type 2; Glycation End Products, Advanced; Glycosylation; Phenols; Plant Extracts; Plant Leaves; Plant Stems; Quercetin; Rutin; Seasons | 2009 |
Catechin prevents endothelial dysfunction in the prediabetic stage of OLETF rats by reducing vascular NADPH oxidase activity and expression.
Topics: Animals; Aorta, Thoracic; Blood Glucose; Blood Pressure; Catechin; Diabetes Mellitus, Type 2; Insulin; Male; NADPH Oxidases; Oxidative Stress; Prediabetic State; Rats; Rats, Inbred OLETF | 2009 |
Antioxidative activity, polyphenolic content and anti-glycation effect of some Thai medicinal plants traditionally used in diabetic patients.
Topics: Antioxidants; Benzothiazoles; Caffeic Acids; Catechin; Diabetes Mellitus, Type 2; Flavonoids; Free Radicals; Gallic Acid; Glycation End Products, Advanced; Humans; Lipid Peroxidation; Medicine, Traditional; Molecular Structure; Oxidative Stress; Phenols; Plant Extracts; Plants, Medicinal; Polyphenols; Pyrogallol; Rutin; Sulfonic Acids; Tannins; Thailand; Thiobarbituric Acid Reactive Substances | 2009 |
Cinchonain Ib isolated from Eriobotrya japonica induces insulin secretion in vitro and in vivo.
Topics: Administration, Oral; Animals; Biflavonoids; Blood Glucose; Catechin; Catechols; Cell Line; Chlorogenic Acid; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Eriobotrya; Female; Glyburide; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Plant Extracts; Plant Leaves; Proanthocyanidins; Pyrones; Rats; Rats, Wistar | 2009 |
Epigallocatechin gallate (EGCG) and rutin suppress the glucotoxicity through activating IRS2 and AMPK signaling in rat pancreatic beta cells.
Topics: AMP-Activated Protein Kinases; Animals; Catechin; Cell Line, Tumor; Diabetes Mellitus, Type 2; Down-Regulation; Glucose; Humans; Insulin Receptor Substrate Proteins; Insulin-Secreting Cells; Rats; Rutin; Signal Transduction | 2009 |
Hypolipidaemic and antioxidative effects of oligonol, a low-molecular-weight polyphenol derived from lychee fruit, on renal damage in type 2 diabetic mice.
Topics: Animals; Antioxidants; Biomarkers; Catechin; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fruit; Glycation End Products, Advanced; Hyperlipidemias; Hypolipidemic Agents; Kidney; Kidney Diseases; Litchi; Male; Mice; Organ Size; Oxidative Stress; Phenols; Reactive Oxygen Species; Thiobarbituric Acid Reactive Substances | 2010 |
The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity.
Topics: alpha-Synuclein; Amyloid; Amyloid beta-Protein Precursor; Animals; Benzothiazoles; Catechin; Cell Culture Techniques; Diabetes Mellitus, Type 2; Flavonoids; Islet Amyloid Polypeptide; Microscopy, Electron, Transmission; Phenols; Polyphenols; Protease Nexins; Rats; Receptors, Cell Surface; Thiazoles | 2010 |
Hypoglycemic activities of A- and B-type procyanidin oligomer-rich extracts from different Cinnamon barks.
Topics: Animals; Antioxidants; Biflavonoids; Blood Glucose; Catechin; Cinnamomum aromaticum; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose Tolerance Test; Hep G2 Cells; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Mice; Phytotherapy; Plant Bark; Plant Extracts; Plants, Medicinal; Proanthocyanidins; Streptozocin | 2011 |
Effects of a catechin-free fraction derived from green tea on gene expression of gluconeogenic enzymes in rat hepatoma H4IIE cells and in the mouse liver.
Topics: Animals; Antioxidants; Carcinoma, Hepatocellular; Catechin; Cell Line, Tumor; Diabetes Mellitus, Type 2; Gene Expression; Gluconeogenesis; Glucose-6-Phosphatase; Hepatocyte Nuclear Factor 4; Insulin; Liver; Male; Mice; Phosphoenolpyruvate Carboxykinase (ATP); Plant Extracts; Plant Leaves; Rats; RNA, Messenger; Tea | 2011 |
Red wine: a source of potent ligands for peroxisome proliferator-activated receptor γ.
Topics: Binding, Competitive; Cardiovascular Diseases; Catechin; Coumaric Acids; Diabetes Mellitus, Type 2; Ellagic Acid; Flavonoids; Gas Chromatography-Mass Spectrometry; Humans; Hypoglycemic Agents; Ligands; Models, Chemical; Phenols; Plant Extracts; Polyphenols; PPAR gamma; Rosiglitazone; Spectroscopy, Fourier Transform Infrared; Thiazolidinediones; Wine | 2011 |
Enhanced autophagy plays a cardinal role in mitochondrial dysfunction in type 2 diabetic Goto-Kakizaki (GK) rats: ameliorating effects of (-)-epigallocatechin-3-gallate.
Topics: Animals; Autophagy; Blood Glucose; Catechin; Diabetes Mellitus, Type 2; Down-Regulation; Fasting; Hypoglycemic Agents; Insulin Resistance; Male; Mitochondria; Mitogen-Activated Protein Kinases; Muscle, Skeletal; Oxidative Stress; Rats; Tumor Suppressor Protein p53; Up-Regulation | 2012 |
Non-covalent interaction of dietary polyphenols with total plasma proteins of type II diabetes: molecular structure/property-affinity relationships.
Topics: Binding Sites; Blood Proteins; Catechin; Diabetes Mellitus, Type 2; Flavanones; Flavones; Flavonols; Food; Gallic Acid; Glycosylation; Humans; Hydrogen Bonding; Hydrogenation; Hydrophobic and Hydrophilic Interactions; Hydroxylation; Isoflavones; Molecular Structure; Plants; Polyphenols; Protein Binding; Spectrometry, Fluorescence; Stilbenes; Structure-Activity Relationship | 2011 |
Alterations in skeletal muscle indicators of mitochondrial structure and biogenesis in patients with type 2 diabetes and heart failure: effects of epicatechin rich cocoa.
Topics: Aged; Beverages; Biomarkers; Biopsy; Cacao; California; Candy; Catechin; Diabetes Mellitus, Type 2; Functional Food; Glycated Hemoglobin; Heart Failure; Humans; Lipids; Middle Aged; Mitochondria, Muscle; Mitochondrial Proteins; Natriuretic Peptide, Brain; Quadriceps Muscle; Time Factors; Treatment Outcome | 2012 |
Quercetin and epigallocatechin gallate induce in vitro a dose-dependent stiffening and hyperpolarizing effect on the cell membrane of human mononuclear blood cells.
Topics: Adult; Aged; Anisotropy; Biomarkers; Cardiovascular Diseases; Catechin; Cell Membrane; Cell Polarity; Diabetes Mellitus, Type 2; Diet, Vegetarian; Female; Humans; Hyperglycemia; Inflammation; Insulin; Insulin Resistance; Leukocytes, Mononuclear; Male; Membrane Fluidity; Membrane Potentials; Middle Aged; Quercetin; Resistin | 2012 |
Diverse mechanisms of antidiabetic effects of the different procyanidin oligomer types of two different cinnamon species on db/db mice.
Topics: Animals; Biflavonoids; Blood Glucose; Catechin; Cinnamomum zeylanicum; Diabetes Mellitus, Type 2; Disease Models, Animal; Female; Humans; Hypoglycemic Agents; Male; Mice; Phytotherapy; Plant Extracts; Proanthocyanidins | 2012 |
Hypoglycemic effect of the water extract of Pu-erh tea.
Topics: Animals; Blood Glucose; Caffeine; Camellia sinensis; Catechin; Diabetes Mellitus, Type 2; Fermentation; Glucose; Glucose Tolerance Test; Glycoside Hydrolases; Hep G2 Cells; Humans; Hypoglycemic Agents; Insulin; Intestinal Mucosa; Male; Mice; Mice, Obese; Plant Extracts; Rats; Rats, Wistar; Swine; Tea | 2012 |
Impairment of sodium pump and Na/H exchanger in erythrocytes from non-insulin dependent diabetes mellitus patients: effect of tea catechins.
Topics: Catechin; Diabetes Mellitus, Type 2; Erythrocytes; Female; Humans; Male; Middle Aged; Molecular Structure; Sodium-Hydrogen Exchangers; Sodium-Potassium-Exchanging ATPase; Structure-Activity Relationship; Tea | 2005 |
Epigallocatechin gallate supplementation alleviates diabetes in rodents.
Topics: Acyl-CoA Oxidase; Adipose Tissue; Animals; Blood Glucose; Carnitine O-Palmitoyltransferase; Catechin; Cell Line, Tumor; Diabetes Mellitus, Type 2; Dietary Supplements; Gene Expression; Gene Expression Regulation; Glucokinase; Glucose; Glucose Tolerance Test; Lipid Metabolism; Liver; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Oligonucleotide Array Sequence Analysis; Phosphoenolpyruvate Carboxykinase (GTP); Rats; Rats, Sprague-Dawley; RNA, Messenger | 2006 |
Dietary supplementation with epigallocatechin gallate elevates levels of circulating adiponectin in non-obese type-2 diabetic Goto-Kakizaki rats.
Topics: Adiponectin; Animals; Catechin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Supplements; Lipid Metabolism; Rats; Rats, Inbred Strains; Triglycerides | 2007 |
Erythrocyte sodium/hydrogen exchange inhibition by (-) epicatechin.
Topics: Adult; Catechin; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Erythrocytes; Humans; Insulin; Middle Aged; Sodium-Hydrogen Exchangers | 2001 |
Insulin-like effect of (-)epicatechin on erythrocyte membrane acetylcholinesterase activity in type 2 diabetes mellitus.
Topics: Acetylcholinesterase; Adult; Catechin; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Erythrocyte Membrane; Female; Humans; Insulin; Male; Middle Aged | 2001 |
Intracellular reduced glutathione content in normal and type 2 diabetic erythrocytes: effect of insulin and (-)epicatechin.
Topics: Adult; Catechin; Diabetes Mellitus, Type 2; Erythrocytes; Female; Glutathione; Humans; Insulin; Male; Middle Aged | 2001 |